Revenues increased by 3,832% year over yearDebt ratio improved to 7% from 75% at year-end 2021SAN DIEGO, CA / ACCESSWIRE / March 31, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company")
31.03.2023 - Revenues increased by 3,832% year over yearDebt ratio improved to 7% from 75% at year-end 2021SAN DIEGO, CA / ACCESSWIRE / March 31, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ( Ainos , or the Company ), a diversified medtech company focused on the .
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Ainos Reports Fourth Quarter and Full Year 2022 Financial Results pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Ainos expands market for VELDONA® low-dose interferon treatment to animal careProducts expected to launch in Taiwan in Q3 2023SAN DIEGO, CA / ACCESSWIRE / March 21, 2023 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW)